bosentan anhydrous has been researched along with Infant, Premature, Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruni, A; Camerini, P; Radicioni, M | 1 |
1 other study(ies) available for bosentan anhydrous and Infant, Premature, Diseases
| Article | Year |
|---|---|
Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.
Topics: Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Nitric Oxide; Persistent Fetal Circulation Syndrome; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2011 |